These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CA 125 serum levels correlated with second-look operations among ovarian cancer patients. Berek JS; Knapp RC; Malkasian GD; Lavin PT; Whitney C; Niloff JM; Bast RC Obstet Gynecol; 1986 May; 67(5):685-9. PubMed ID: 3457330 [TBL] [Abstract][Full Text] [Related]
4. The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer. Gallion HH; Hunter JE; van Nagell JR; Averette HE; Cain JM; Copeland LJ; Higgins RV; Husseinzadeh N; Nahhas WA; Partridge EE Gynecol Oncol; 1992 Jul; 46(1):29-32. PubMed ID: 1634137 [TBL] [Abstract][Full Text] [Related]
5. Measurement of the ovarian cancer-associated antigen CA 125 prior to second look operation. Mogensen O; Mogensen B; Jakobsen A; Sell A Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1835-7. PubMed ID: 3220081 [TBL] [Abstract][Full Text] [Related]
6. Alpha 1-acid glucoprotein in ovarian cancer with a reference to immunosuppressive acidic protein and cancer antigen 125. Mogensen O; Mogensen B; Jakobsen A Cancer; 1989 Nov; 64(9):1867-71. PubMed ID: 2477138 [TBL] [Abstract][Full Text] [Related]
7. Use of CA 125 to monitor patients with ovarian epithelial carcinomas. Podczaski E; Whitney C; Manetta A; Larson JE; Kirk J; Stevens CW; Lyter J; Mortel R Gynecol Oncol; 1989 May; 33(2):193-7. PubMed ID: 2703180 [TBL] [Abstract][Full Text] [Related]
8. [Serum level of the tumor marker CA 125 before second-look laparatomy in primary epithelial ovarian cancer in relation to intraoperative findings]. Meden H; Rath W; Teichmann A; Kuhn W Onkologie; 1989 Oct; 12(5):217-20. PubMed ID: 2685687 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of multiple tumor marker assays in second-look procedures for ovarian cancer. Benedetti Panici P; Scambia G; Baiocchi G; Iacobelli S; Mancuso S Gynecol Oncol; 1989 Dec; 35(3):286-9. PubMed ID: 2599461 [TBL] [Abstract][Full Text] [Related]
11. CA 125 measured before second-look laparotomy is an independent prognostic factor for survival in patients with epithelial ovarian cancer. Makar AP; Kristensen GB; Børmer OP; Tropé CG Gynecol Oncol; 1992 Jun; 45(3):323-8. PubMed ID: 1612511 [TBL] [Abstract][Full Text] [Related]
12. Prediction of the presence of ovarian cancer at surgery by an immunochemical panel: CA 125 and copper-to-zinc ratio. Gal D; Lischinsky S; Friedman M; Zinder O Gynecol Oncol; 1989 Nov; 35(2):246-50. PubMed ID: 2680799 [TBL] [Abstract][Full Text] [Related]
13. Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer. Rubin SC; Hoskins WJ; Hakes TB; Markman M; Reichman BS; Chapman D; Lewis JL Am J Obstet Gynecol; 1989 Mar; 160(3):667-71. PubMed ID: 2648838 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of CA 125 and histological findings at second-look laparotomy in ovarian carcinoma. Meier W; Stieber P; Eiermann W; Schneider A; Fateh-Moghadam A; Hepp H Gynecol Oncol; 1989 Oct; 35(1):44-6. PubMed ID: 2792900 [TBL] [Abstract][Full Text] [Related]
15. Value of serum 125Ca levels: does the result preclude second look? Potter ME; Moradi M; To AC; Hatch KD; Shingleton HM Gynecol Oncol; 1989 May; 33(2):201-3. PubMed ID: 2703182 [TBL] [Abstract][Full Text] [Related]
16. Predictive values of CA 125 antigen levels and CT scan in second-look procedures for ovarian cancer. Aravantinos D; Michalas S; Papazefkos V; Christoforaki M; Stypsaneli A; Vlachos G; Athanasiadis P Eur J Obstet Gynecol Reprod Biol; 1990 Dec; 37(3):265-70. PubMed ID: 2227069 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer. Koelbl H; Schieder K; Neunteufel W; Bieglmayer C Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933 [TBL] [Abstract][Full Text] [Related]
18. Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease? Patsner B; Orr JW; Mann WJ; Taylor PT; Partridge E; Allmen T Gynecol Oncol; 1990 Jun; 37(3):319-22. PubMed ID: 2190870 [TBL] [Abstract][Full Text] [Related]
19. The role of the CA 125 assay in the management of ovarian cancer. Niloff JM Oncology (Williston Park); 1988 Aug; 2(8):67-76. PubMed ID: 3275060 [TBL] [Abstract][Full Text] [Related]
20. Measurement of the ovarian cancer-associated antigen CA 125 in monitoring tumor burden and response to chemotherapy. Quaranta M; Coviello M; Donadeo A; Rella C; Lorusso V; Micelli G; Lucarelli C Tumori; 1991 Apr; 77(2):167-9. PubMed ID: 2048231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]